Development and validation of a high-performance liquid chromatography with tandem mass spectrometry method for quantification of tofacitinib in human plasma

Introduction. The use of tofacitinib as a pharmacological treatment for rheumatoid arthritis remains relevant in the light of the predicted increase in prevalence of the disease. At the same time, due to the withdrawal of several foreign pharmaceutical companies from the Russian pharmaceutical marke...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E. S. Vetrova, P. K. Karnakova, N. S. Bagaeva, K. K. Karnakova, M. O. Popova, A. A. Popova, O. A. Archakova, T. N. Komarov, I. E. Shohin
Formato:	Artigo
Idioma:	Russo
Publicado em:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2024-06-01
coleção:	Разработка и регистрация лекарственных средств
Assuntos:	tofacitinib validation lc-ms/ms bioequivalence pharmacokinetics bioanalytical study
Acesso em linha:	https://www.pharmjournal.ru/jour/article/view/1838
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!